Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-23T21:25:51.774Z Has data issue: false hasContentIssue false
  • English
  • Français

Nonparametric Linkage Analysis Between Schizophrenia and Candidate Genes of Dopaminergic and Serotonergic Systems

Published online by Cambridge University Press:  07 November 2014

Alda M. Ambrósio ,
James L. Kennedy ,
Fabio Macciardi ,
Isabel Coelho ,
Maria J. Soares ,
Catarina R. Oliveira ,
Michele T. Pato  and
Carlos N. Pato
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Alterations in dopaminergic and serotonergic systems have been implicated in the pathophysiology of schizophrenia for many years. This study was performed to assess the possible involvement of the dopamine receptor genes D2 (DRD2), D3, D4, serotonin receptor genes 1Dα, 1Dβ, and 2A in the etiology of schizophrenia.

Methods:

We examined 33 multiplex schizophrenic families from Portugal.

Results:

Linkage analysis performed by GENE-HUNTER showed nonsignificant linkage for these genes. A maximum nonparametric linkage score of 1.635 (P=.032) at DRD2 gene was observed, and this finding suggests DRD2 gene for further studies.

Conclusion:

the polymorphisms studied at dopamine receptor genes D3, D4, serotonin receptor genes 1Dα, 1Dβ, and 2A do not have a major effect in susceptibility to schizophrenia in a Portuguese population.

Type
Original Research
Information
CNS Spectrums , Volume 9 , Issue 4 , April 2004 , pp. 302 - 308
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. McGuffin, P, Owen, MJ, Farmer, AE. The genetic basis of schizophrenia. Lancet. 1995;346:678–682.CrossRefGoogle ScholarPubMed
2. Risch, N. Genetic linkage and complex diseases, with special refetence to psychiatric disorders. Genet Epidemiol. 1990;7:3–16.CrossRefGoogle ScholarPubMed
3. Joyce, JN. The dopamine hypothesis of schizophrenia: limbic interaction with serotonin and neurotrophin. Psychopharmacology (Berl). 1993;112(1 suppl):S16–S34.CrossRefGoogle Scholar
4. Van Tol, HH, Bunzow, JR, Guan, HC, et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 1991;350:610–614.CrossRefGoogle ScholarPubMed
5. Sokoloff, P, Giros, B, Martres, MP, Bouthenet, ML, Schwartz, JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990;347:146–151.CrossRefGoogle ScholarPubMed
6. Kennedy, JL, Billett, EA, Macciardi, F, et al. Association study of dopamine D3 receptor gene and schizophrenia. Am J Med Genet. 1995;60:558–562.CrossRefGoogle ScholarPubMed
7. Dubertret, C, Gorwood, P, Ades, J, Feingold, J, Schwartz, JC, Sokoloff, P. Meta-analysis of DRD3 gene and schizophrenia: Ethnic heterogeneity and significant association in Caucasians. Am J Med Genet. 1998;81:318–322.3.0.CO;2-P>CrossRefGoogle ScholarPubMed
8. Spurlock, G, Williams, J, McGuffin, P, et al. European multicentre association study of schizophrenia: a study of the DRD2 Ser 311Cys and DRD3 Ser 9Gly polymorphisms. Am J Med Genet. 1998;81:24–28.3.0.CO;2-N>CrossRefGoogle Scholar
9. Williams, J, Spurlock, G, Holmans, P, et al. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol Psychiatry. 1998;3:141–149.CrossRefGoogle ScholarPubMed
10. Basile, VS, Masellis, M, Badri, F, et al. Association of MscI polymorphism of the dopamine D3 Receptor gene with tardive dyskinesia in schizophrenia. Neuropsychopharmacology. 1999;21:17–27.CrossRefGoogle ScholarPubMed
11. Segman, R, Neeman, T, Heresco-Levy, H, et al. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry. 1999;4:247–253.CrossRefGoogle ScholarPubMed
12. Prasad, S, Deshpande, SN, Bhatia, T, et al. Association study of schizophrenia among Indian families. Am J Med Genet. 1999;88:298–300.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
13. Henderson, AS, Korten, AE, Jorm, AF, et al. COMT and DRD3 polymorphism, environmental exposures, and personality traits related to common mental disorders. Am J Med Genet. 2000;96:102–107.3.0.CO;2-3>CrossRefGoogle ScholarPubMed
14. Kunovac, JL, Stahl, SM. Biochemical pharmacology of serotonin receptor subtypes: Hypotheses for clinical applications of selective serotonin ligands. Int Rev Psychiatry. 1995;7:55–67.CrossRefGoogle Scholar
15. Meltzer, HY. Biological studies in schizophrenia. Schizophr Bull. 1987;13:77–111.CrossRefGoogle ScholarPubMed
16. Bleich, A, Brown, SL, Kahn, R, van Praag, HM. The role of serotonin in schizophrenia. Schizophr Bull. 1988;14:297–315.CrossRefGoogle ScholarPubMed
17. Hamblin, MW, Metcalf, MA. Primary structure and functional characterization of a human 5T1D-type serotonin receptor. Mol Pharmacol. 1991;40:143–148.Google ScholarPubMed
18. Demchyshyn, L, Sunahara, R, Miller, K, et al. A human serotonin 1D receptor variant (5HT1Dbeta) encoded by an intronless gene on chromosome 6. Proc Natl Acad Sci USA. 1992;89:5522–5526.CrossRefGoogle Scholar
19. Libert, F, Passage, E, Parmentier, M, Simons, MJ, Vassart, G, Mattei, MG. Chromosomal mapping of Al and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor. Genomics. 1991;11:225–227.CrossRefGoogle Scholar
20. Arranz, M, Collier, D, Sodhi, M, et al. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet. 1995;346:281–82.CrossRefGoogle ScholarPubMed
21. Arranz, M, Collier, D, Munro, J, et al. Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neurosci Lett. 1996;217:177–178.CrossRefGoogle ScholarPubMed
22. Malhotra, AK, Goldman, D, Ozaki, N, Breier, A, Buchanan, R, Pickar, D. Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine. Am J Psychiatry. 1996;153:1092–1094.Google ScholarPubMed
23. Arranz, M, Munro, J, Owen, MJ, et al. Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol Psychiatry. 1998;3:61–66.CrossRefGoogle ScholarPubMed
24. Masellis, M, Basile, V, Meltzer, HY, et al. Serotinin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology. 1998;19:123–132.CrossRefGoogle Scholar
25. Leysen, JE, Janssen, PM, Gommeren, W, Wynants, J, Pauwels, PJ, Janssen, PA. In vitro and vivo receptor binding and effects on monoamine turnover in rat brain of the novel antipychotics risperidone and ocaperidone. Mol Pharmacol. 1992;41:494–508.Google Scholar
26. Meltzer, HY. The role of serotonin in antipsychotic drug action. Neuropsychopharmocology. 1999;21:106–115.CrossRefGoogle ScholarPubMed
27. Chen, K, Yang, W, Grimsby, J, et al. The human 5HT2 receptor is encoded by a multiple intron-exon gene. Mol Brain Res. 1992;14:20–26.CrossRefGoogle ScholarPubMed
28. Erdmann, J, Shimron-Abarbanel, D, Rietschel, M, et al. Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet. 1996;97:614–619.CrossRefGoogle ScholarPubMed
29. Inayama, Y, Yoneda, H, Sakai, T, et al. Positive association between a DNA sequence variant in the serotonin 2A gene and schizophrenia. Am J Med Genet. 1996;67:103–105.3.0.CO;2-S>CrossRefGoogle ScholarPubMed
30. Williams, J, Spurlock, G, McGuffin, P, et al. Association between schizophrenia and T102C polymorphism of 5-hydroxytriptamine type 2a-receptor gene. Lancet. 1996;347:1294–1296.CrossRefGoogle Scholar
31. Verga, M, Macciardi, F, Cohen, S, et al. No association between schizophrenia and the serotonin receptor 5HT2a in a Italian population. Am J Med Genet. 1997;74:21–25.3.0.CO;2-Y>CrossRefGoogle Scholar
32. Segman, RH, Heresco-Levy, U, Finkel, B, et al. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry. 2001;6:225–229.CrossRefGoogle ScholarPubMed
33. Serretti, A, Cusi, C, Lorenzi, C, et al. Serotonin-2A receptor gene is not associated with symptomatology of schizophrenia. Am J Med Genet. 2000;96:84–87.3.0.CO;2-9>CrossRefGoogle Scholar
34. Schindler, K, Torre, CD, Bauer, A, et al. Identification of a highly homogenous population for genetic study of psychiatric disorders. CNS Spectr. 1999;4:22–24.CrossRefGoogle Scholar
35. Pato, CN, Azevedo, MH, Pato, MT, et al. Selection of homogeneous populations for genetic study: the Portugal Genetics of Psychosis Project. Am J Med Genet. 1997;74:286–288.3.0.CO;2-O>CrossRefGoogle Scholar
36. Nurnberger, JL, Blehar, MC, Kaufmann, CA, et al. Diagnostic Interview for Genetics Studies. Rationale, unique features, and training. Arch Gen Psychiatry. 1994;51:849–859.CrossRefGoogle ScholarPubMed
37. Azevedo, MH, Valente, J, Macedo, A, et al. Versão Portuguesa da entrevista diagnóstica para estudos genéticos. Psiduiatria Címica. 1993;14:213–217.Google Scholar
38. McGuffin, P, Farmer, AE, Harvey, JL. A polydiagnostic application of the operational criteria in studies of psychotic illness. Arch Gen Psychiatry. 1991;48:764–770.CrossRefGoogle ScholarPubMed
39. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.Google Scholar
40. Miller, SA, Dykes, DD, Polesky, HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.CrossRefGoogle ScholarPubMed
41. Grandy, DK, Zhang, Y, Civelli, O. PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet. 1993;2:2197.CrossRefGoogle ScholarPubMed
42. Arinami, T, Itokawa, M, Enguchi, H, et al. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet. 1994;343:703–704.CrossRefGoogle ScholarPubMed
43. Lannfelt, L, Sokoloff, P, Martres, MP, et al. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigation psychiatric disorders. Psychiotr Genet. 1992;2:249–256.CrossRefGoogle Scholar
44. Barr, CL, Feng, Y, Wigg, KG, et al. 5'-Untranslated region of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet. 2001;105:84–90.3.0.CO;2-Q>CrossRefGoogle ScholarPubMed
45. Lichter, JB, Barr, CL, Kennedy, JL, et al. A hypervariable segment in the dopamine receptor D4 (DRD4) gene. Hum Mol Genet. 1993;6:767–773.CrossRefGoogle Scholar
46. Ozaki, N, Lappalainen, J, Dean, M, Virkkunen, M, Linnoila, M, Goldman, D. Mapping of the serotonin 5-HT1D alpha autoreceptor gene (HTR1D) on chromosome 1 using a silent polymorphism in the coding region. Am J Med Genet. 1995;60:162–164.CrossRefGoogle ScholarPubMed
47. Nothen, MM, Erdmann, J, Shimron-Abarbanell, D, Propping, P. Identification of genetic variation in the human serotonin 1D beta receptor gene. Biochem Biophys Res Commun. 1994;205:1194–1200.CrossRefGoogle ScholarPubMed
48. Lappalainen, J, Dean, M, Charbonneau, L, Virkkunen, M, Linnoila, M, Goldman, D. Mapping of the serotonin 5-HT1D beta autoreceptor gene on chromosome 6 and direct analysis for sequence variants. Am J Med Genet. 1995;60:157–161.CrossRefGoogle ScholarPubMed
49. Warren, JT Jr, Peacock, ML, Rodriguez, LC, Fink, JK. An Mspi polymorphism in the human serotonin receptor gene (5HT2): detection by DGGE and RFLP analysis. Hum Mol Genet. 1993;2:338.CrossRefGoogle Scholar
50. Kruglyak, L, Daly, MJ, Reeve-Daly, MR, et al. Parametric and non-parametric analysis: A unified multipoint approach. Am J Hum Genet. 1996;59:1347–1363.Google Scholar
51. Baron, M. Genetics of schizophrenia and the new millennium: progress and pitfall. Am J Hum Genet. 2001;68:299–312.CrossRefGoogle Scholar
52. Lander, ES, Kruglyak, L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241–247.CrossRefGoogle ScholarPubMed
53. Gurling, HM, Kalsi, G, Brynjolfson, J, et al. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2,5q33.2 and 8p21.22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-1123. Am J Hum Genet. 2001;68:661–673.CrossRefGoogle Scholar
54. Moises, HW, Gelernter, J, Giuffra, LA, et al. No linkage between D2 dopamine receptor gene region and schizophrenia. Arch Gen Psychiatry. 1991;48:643–647.CrossRefGoogle ScholarPubMed
55. Su, Y, Burke, J, O'neil, FA, et al. Exclusion of linkage between schizophrenia and the D2 dopamine receptor gene region of chromosome 11q in 112 Irish multiplex families. Arch Gen Psychiatry. 1993;50:205–211.Google ScholarPubMed
56. Kalsi, G, Mankoo, BS, Curtis, D, et al. Exclusion of linkage of schizophrenia to the gene for the dopamine D2 receptor (DRD2) and chromosome 11q translocation sites. Psychol Med. 1995;25:531–537.CrossRefGoogle Scholar
57. Nanko, S, Fukud, R, Hattori, M, et al. Further evidence of no linkage between schizophrenia and the dopamine D3 receptor gene locus. Am J Med Genet. 1994;54:264–267.CrossRefGoogle ScholarPubMed
58. Sabaté, O, Campion, D, D'Amato, T, et al. Failure to find evidence for linkage or association between the dopamine D3 receptor gene and schizophrenia. Am J Psychiatry. 1994;151:107–111.Google ScholarPubMed
59. Asherson, P, Mant, R, Holmans, P, et al. Linkage, association and mutational analysis of the dopamine D3 receptor gene in schizophrenia. Mol Psychiatry. 1996;1:125–132.Google ScholarPubMed
60. Kalsi, G, Curtis, D, Brynjolfsson, J, et al. Test of linkage, allelic and genotypic association between schizophrenia and the gene for the D3 dopamine receptor DRD3. Psychiatr Genet. 1998;8:187–189.CrossRefGoogle Scholar
61. Barr, CL, Kennedy, JL, Lichter, JB, et al. Alleles at the dopamine D4 receptor locus do not contribute to the genetic susceptibility to schizophrenia in a large Swedish kindred. Am J Med Genet. 1993;48:218–222.CrossRefGoogle ScholarPubMed
62. Kennedy, JL, Van Tol, HHM, Petronis, A, et al. Dopamine D4 receptor gene variants gene variants and schizophrenia. Schizophr Res. 1993;9:122.CrossRefGoogle Scholar
63. Macciardi, F, Verga, M, Kennedy, JL, et al. An association study between schizophrenia and the dopamine receptor genes DRD3 and DRD4 using the haplotype relative risk. Hum Hered. 1994;44:328–336.CrossRefGoogle ScholarPubMed
64. Shaikh, S, Gill, M, Owen, M, et al. Failure to find linkage between functional polymorphism in the dopamine D4 receptor gene and schizophrenia. Am J Med Genet. 1994;54:8–11.CrossRefGoogle ScholarPubMed
65. Coelho, I, Macedo, A, Valente, J, et al. Association study of serotonin receptors and schizophrenia in a Portuguese population. Psiquiatria Clínica. 1997;18:41–47.Google Scholar
66. Sidenbetg, G, Basset, AS, Demchyshyn, L, et al. New polymorphism for the human serotonin 1D receptor variant (5-HT1D beta) not linked to schizophrenia in five Canadian pedigrees. Hum Hered. 1993;43:315–318.CrossRefGoogle Scholar
67. Hovatta, L, Varilo, T, Suvisaari, J, et al. A genomewide screen for schizophrenia genes in a isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet. 1999;65:1114–1124.CrossRefGoogle Scholar
68. Brzustowicz, LM, Hodgkinson, KA, Chow, EWC, et al. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science. 2000;288:678–672.CrossRefGoogle Scholar
69. Brzustowicz, LM, Honer, WG, Chow, EW, et al. Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet. 1999;65:1096–1103.CrossRefGoogle ScholarPubMed